Multicentric Castleman disease revealing complete signal transducer and activator of transcription 1 deficiency treated by JAK1/2 inhibition

J Allergy Clin Immunol Pract. 2021 Oct;9(10):3838-3840.e1. doi: 10.1016/j.jaip.2021.06.031. Epub 2021 Jul 2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Castleman Disease* / diagnosis
  • Castleman Disease* / drug therapy
  • Humans
  • Janus Kinase 1 / genetics
  • STAT1 Transcription Factor
  • STAT3 Transcription Factor

Substances

  • STAT1 Transcription Factor
  • STAT3 Transcription Factor
  • JAK1 protein, human
  • Janus Kinase 1